Cypherpunk Technologies Ord Shs
CYPH1.575USD
+0.135+9.38%
交易中 （美東）報價延遲15分鐘
65.27M總市值
虧損本益比TTM
關於 公司
Cypherpunk Technologies Ord Shs簡介
公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -
Cypherpunk Technologies Ord Shs公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Douglas E. (Doug) Onsi
Mr. Douglas E. (Doug) Onsi
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
140.87K
+30.09%
Dr. Christopher K. Mirabelli, Ph.D.
Dr. Christopher K. Mirabelli, Ph.D.
Director
Director
23.05K
--
Ms. Christine Granfield
Ms. Christine Granfield
Vice President, Head - Regulatory Affairs and Quality
Vice President, Head - Regulatory Affairs and Quality
15.90K
--
Dr. Jason Baum, Ph.D.
Dr. Jason Baum, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
15.90K
--
Dr. James H. Cavanaugh, Ph.D.
Dr. James H. Cavanaugh, Ph.D.
Independent Director
Independent Director
214.00
--
Dr. William W. Li, M.D.
Dr. William W. Li, M.D.
Independent Director
Independent Director
--
--
Ms. Patricia (Patty) Martin
Ms. Patricia (Patty) Martin
Independent Director
Independent Director
--
--
Mr. William (Wil) Mcevoy
Mr. William (Wil) Mcevoy
Chief Investment Officer, Director
Chief Investment Officer, Director
--
--
Mr. Christian M. Richard
Mr. Christian M. Richard
Independent Director
Independent Director
--
--
Dr. Richard L. Schilsky, M.D.
Dr. Richard L. Schilsky, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Douglas E. (Doug) Onsi
Mr. Douglas E. (Doug) Onsi
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
140.87K
+30.09%
Dr. Christopher K. Mirabelli, Ph.D.
Dr. Christopher K. Mirabelli, Ph.D.
Director
Director
23.05K
--
Ms. Christine Granfield
Ms. Christine Granfield
Vice President, Head - Regulatory Affairs and Quality
Vice President, Head - Regulatory Affairs and Quality
15.90K
--
Dr. Jason Baum, Ph.D.
Dr. Jason Baum, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
15.90K
--
Dr. James H. Cavanaugh, Ph.D.
Dr. James H. Cavanaugh, Ph.D.
Independent Director
Independent Director
214.00
--
Dr. William W. Li, M.D.
Dr. William W. Li, M.D.
Independent Director
Independent Director
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 12月10日 週三
更新時間: 12月10日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Winklevoss Capital Management, LLC
14.62%
Severns (Sean Michael)
10.59%
Gilead Sciences Inc
9.39%
BofA Global Research (US)
2.55%
Acadian Asset Management LLC
2.18%
其他
60.66%
持股股東
持股股東
佔比
Winklevoss Capital Management, LLC
14.62%
Severns (Sean Michael)
10.59%
Gilead Sciences Inc
9.39%
BofA Global Research (US)
2.55%
Acadian Asset Management LLC
2.18%
其他
60.66%
股東類型
持股股東
佔比
Family Office
14.62%
Corporation
11.53%
Individual Investor
10.99%
Investment Advisor
6.62%
Investment Advisor/Hedge Fund
3.10%
Research Firm
2.88%
Venture Capital
1.25%
Hedge Fund
0.35%
Bank and Trust
0.01%
其他
48.66%
機構持股
更新時間: 12月9日 週二
更新時間: 12月9日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
105
8.04M
14.20%
-12.16M
2025Q3
110
8.07M
14.70%
-12.52M
2025Q2
113
9.14M
22.07%
-11.90M
2025Q1
128
12.05M
29.23%
-8.23M
2024Q4
125
14.62M
38.15%
-3.38M
2024Q3
131
15.40M
40.26%
-3.07M
2024Q2
132
15.45M
40.57%
-950.02K
2024Q1
142
9.18M
39.05%
-1.80M
2023Q4
148
7.57M
32.79%
-3.85M
2023Q3
162
8.45M
36.23%
-2.60M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Gilead Sciences Inc
5.32M
12.84%
--
--
Sep 30, 2025
BofA Global Research (US)
1.44M
2.55%
+1.44M
+451295.63%
Sep 30, 2025
Acadian Asset Management LLC
1.24M
2.18%
--
--
Sep 30, 2025
Beigene Ltd
1.22M
2.15%
+1.22M
--
Oct 31, 2024
The Vanguard Group, Inc.
1.16M
2.05%
--
--
Sep 30, 2025
Hightower Advisors, LLC
1.10M
1.95%
+8.00K
+0.73%
Sep 30, 2025
Simplify Asset Management Inc
975.61K
1.72%
+118.25K
+13.79%
Sep 30, 2025
HealthCare Ventures LLC
697.23K
1.68%
+20.91K
+3.09%
Apr 21, 2025
查看更多
持股ETF
更新時間: 12月9日 週二
更新時間: 12月9日 週二
機構名稱
佔比
Simplify Health Care ETF
0.37%
DFA Dimensional US Sustainability Core 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
0%
Dimensional US Core Equity 1 ETF
0%
Simplify Health Care ETF
佔比0.37%
DFA Dimensional US Sustainability Core 1 ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%
iShares Micro-Cap ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Cypherpunk Technologies Ord Shs的前五大股東是誰？
Cypherpunk Technologies Ord Shs的前五大股東如下：
Gilead Sciences Inc持有股份：5.32M佔總股份比例：12.84%。
BofA Global Research (US)持有股份：1.44M佔總股份比例：2.55%。
Acadian Asset Management LLC持有股份：1.24M佔總股份比例：2.18%。
Beigene Ltd持有股份：1.22M佔總股份比例：2.15%。
The Vanguard Group, Inc.持有股份：1.16M佔總股份比例：2.05%。
Gilead Sciences Inc持有股份：5.32M佔總股份比例：12.84%。
BofA Global Research (US)持有股份：1.44M佔總股份比例：2.55%。
Acadian Asset Management LLC持有股份：1.24M佔總股份比例：2.18%。
Beigene Ltd持有股份：1.22M佔總股份比例：2.15%。
The Vanguard Group, Inc.持有股份：1.16M佔總股份比例：2.05%。
Cypherpunk Technologies Ord Shs的前三大股東類型是什麼？
Cypherpunk Technologies Ord Shs 的前三大股東類型分別是：
Winklevoss Capital Management, LLC
Severns (Sean Michael)
Gilead Sciences Inc
Winklevoss Capital Management, LLC
Severns (Sean Michael)
Gilead Sciences Inc
有多少機構持有Cypherpunk Technologies Ord Shs(CYPH)的股份？
截至2025Q4，共有105家機構持有Cypherpunk Technologies Ord Shs的股份，合計持有的股份價值約為8.04M，占公司總股份的14.20% 。與2025Q3相比，機構持股有所增加，增幅為-0.50%。
哪個業務部門對Cypherpunk Technologies Ord Shs的收入貢獻最大？
在--，--業務部門對Cypherpunk Technologies Ord Shs的收入貢獻最大，創收--，占總收入的--% 。
